10
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T40254 |
MRTX-1719
|
Histone Methyltransferase | Chromatin/Epigenetic |
MRTX-1719 是有效的PRMT5/MTA 复合体选择性抑制剂,其对PRMT5/MTAMTAPDELSDMA 细胞系的IC50值为 <10 nM。 | |||
T9575 |
MRTX9768
|
Histone Methyltransferase | Chromatin/Epigenetic |
MRTX-9768 是一种有效的、选择性的、具有口服活性的 PRMT5-MTA 复合体抑制剂,可选择性靶向 MTAP/CDKN2A 缺失的肿瘤。 | |||
T76890 |
Petosemtamab
MCLA 158 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Petosemtamab (MCLA 158) 是一种高效的抗 EGFR (Kd: 0.22 nM) 和抗 LGR5 (Kd: 0.86 nM) 单克隆抗体。Petosemtamab 促使 LGR5+ 癌细胞中的 EGFR 信号传导中断和受体分解。Petosemtamab 可用于头颈部鳞状细胞癌 (HNSCC)、转移性结直肠癌 (CRC) 等实体瘤的研究。 | |||
T77007 | Fidasimtamab | ||
Fidasimtamab (IBI-315; BH2950)为一重组人IgG1双特异性抗体,能同时针对HER2及PD-1进行靶向、结合与抑制,进而影响其下游信号通路。此外,该物质通过连接表达PD-1的T细胞与表达HER2的肿瘤细胞,展现其潜在的免疫抑制及抗肿瘤活性。 | |||
T78760 |
MTase-IN-1
|
SARS-CoV | Microbiology/Virology |
MTase-IN-1 (compound 26) 作为冠状病毒nsp14 N7-甲基转移酶的选择性抑制剂,显示出高效活性,其IC50值为0.72 nM。此外,MTase-IN-1 能够干扰病毒RNA的翻译过程和其免疫逃避机制。 | |||
T75029 | HEMTAC CDK4/6 degrader 1 | ||
HEMTAC CDK4/6 degrader 1 是一种通过连接HSP90的配体和CDK4/6而形成的PROTAC,其Kd值为35.7 µM。在B16F10黑色素瘤细胞中,该化合物能够诱导CDK4/6的降解,从而将细胞周期阻滞在G0/G1期,并引发细胞凋亡。因此,HEMTAC CDK4/6 degrader 1可被应用于癌症研究领域。 | |||
T36647 | Trastuzumab emtansine | Others | Others |
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that combines the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of DM1, a microtubule-inhibitory derivative of maytansine. This compound is utilized in the investigation of advanced breast cancer[1][2]. | |||
T125576 |
Umtatin
|
||
Umtatin 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T125576。 | |||
T79873 |
TNG-462
|
Histone Methyltransferase | Chromatin/Epigenetic |
TNG-462(化合物1143)作为一种口服有效的PRMT5抑制剂,适用于研究MTAP缺失型及/或MTA累积型癌症。 | |||
T36630 | MRTX9768 hydrochloride | ||
MRTX9768 hydrochloride is a potent, orally active PRMT5 inhibitor. MRTX9768 hydrochloride is a synthetic lethal-based inhibitor binding the PRMT5-MTA complex[1]. MRTX9768 inhibits SDMA and cell proliferation in HCT116 MTAP-del cells (SDMA IC50 3 nM; prolif. IC50 11 nM) with marked selectivity over HCT116 MTAP-WT cells (SDMA IC50 544 nM; prolif. IC50 861 nM)[1].MRTX9768 selectively targets MTAP/CDKN2A-deleted tumors[2][1]. In xenograft studies, oral administration of MRTX9768 demonstrates dose-de... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8227 |
5'-Methylthioadenosine
Methylthioadenosine,5-脱氧-5-甲硫腺苷,5'-(Methylthio)-5'-deoxyadenosine,5'-Deoxy-5'-(methylthio)adenosine,5'-S-Methyl-5'-thioadenosine |
Endogenous Metabolite | Metabolism |
5'-Methylthioadenosine (Methylthioadenosine) 是由 S-腺苷蛋氨酸在多胺合成过程中生成的核苷,通过抑制肿瘤细胞增殖、侵袭和诱导细胞凋亡来抑制肿瘤,同时控制肿瘤组织的炎症微环境。 | |||
T25253 |
Cinnamtannin B-1
Cinnamtannin B1 (constituent of cinnamomum verum bark),LDN 0022358,LDN-0022358,LDN0022358,肉桂单宁B-1 |
Antioxidant; COX | Immunology/Inflammation; Neuroscience; oxidation-reduction |
Cinnamtannin B-1 (LDN 0022358) 是一种 A 型原花青素,包含在多种植物中,如越桔、桂树、泽兰肉桂和猪苓。它是一种有效的抗氧化剂和保护剂,可对抗人类血小板的氧化应激和凋亡。它是一种 Cox-2抑制剂。 | |||
T82721 |
Cinnamtannin B2
|
||
Cinnamtannin B2(化合物12)为肉桂单宁类化合物,可自越橘(Vaccinium vitis-idaea L.)中提取。 | |||
T82720 |
Cinnamtannin D2
|
||
Cinnamtannin D2(化合物13)是从越橘(Vaccinium vitis-idaea L.)中分离的一种肉桂单宁。 | |||
T40977 |
Cinnamtannin A2
肉桂鞣质A2 |
||
Cinnamtannin A2, a tetrameric procyanidin, enhances GLP-1 and insulin secretion in mice while also upregulating the expression of corticotrophin releasing hormone. Additionally, Cinnamtannin A2 exhibits antioxidant, anti-diabetic, and nephroprotective effects. |